Presentation is loading. Please wait.

Presentation is loading. Please wait.

Long-term Effect of Chronic Oral Anticoagulation with Warfarin after Acute Myocardial Infarction  Salman A. Haq, MD, John F. Heitner, MD, Terrence J.

Published byEgil Thorvaldsen Modified over 5 years ago

Similar presentations

Presentation on theme: "Long-term Effect of Chronic Oral Anticoagulation with Warfarin after Acute Myocardial Infarction  Salman A. Haq, MD, John F. Heitner, MD, Terrence J."— Presentation transcript:

1 Long-term Effect of Chronic Oral Anticoagulation with Warfarin after Acute Myocardial Infarction 
Salman A. Haq, MD, John F. Heitner, MD, Terrence J. Sacchi, MD, Sorin J. Brener, MD  The American Journal of Medicine  Volume 123, Issue 3, Pages (March 2010) DOI: /j.amjmed Copyright © 2010 Elsevier Inc. Terms and Conditions

2 Figure 1 Study inclusion and exclusion process. OAC=oral anticoagulation. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2010 Elsevier Inc. Terms and Conditions

3 Figure 2 Forester plot of effect of long-term oral anticoagulation on mortality (point estimate proportional to number of events, odds ratio <1 indicates benefit for oral anticoagulation). OAC=oral anticoagulation; ATACS=Antithrombotic Therapy in Acute Coronary Syndromes Study; WARIS=Warfarin Aspirin Re-infarction Study; AFTER=Aspirin/Anticoagulants Following Thrombolysis with Eminase in Recurrent infarction study; CARS=Coumadin Aspirin Reinfarction Study; ASPECT=Aspirin and Coumadin after Acute Coronary Syndromes study; CHAMP=Combination Hemotherapy and Mortality Prevention study; APRICOT=Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis; LoWASA=Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction study. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2010 Elsevier Inc. Terms and Conditions

4 Figure 3 Forester plot of effect of long-term oral anticoagulation on nonfatal stroke (point estimate proportional to number of events, odds ratio <1 indicates benefit for oral anticoagulation). OAC=oral anticoagulation; WARIS=Warfarin Aspirin Re-infarction Study; CARS=Coumadin Aspirin Reinfarction Study; ASPECT=Aspirin and Coumadin after Acute Coronary Syndromes study; CHAMP=Combination Hemotherapy and Mortality Prevention study; LoWASA=Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction study. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2010 Elsevier Inc. Terms and Conditions

5 Figure 4 Forester plot of effect of long-term oral anticoagulation on nonfatal major bleeding (point estimate proportional to number of events, odds ratio >1 indicates excess with oral anticoagulation). OAC=oral anticoagulation; WARIS=Warfarin Aspirin Re-infarction Study; ATACS=Antithrombotic Therapy in Acute Coronary Syndromes Study; CARS=Coumadin Aspirin Reinfarction Study; ASPECT=Aspirin and Coumadin after Acute Coronary Syndromes study; CHAMP=Combination Hemotherapy and Mortality Prevention study; APRICOT=Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis; LoWASA=Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction study. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2010 Elsevier Inc. Terms and Conditions

Download ppt "Long-term Effect of Chronic Oral Anticoagulation with Warfarin after Acute Myocardial Infarction  Salman A. Haq, MD, John F. Heitner, MD, Terrence J."

Similar presentations

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.
An Unusual Electrocardiogram in a Heart Transplant Recipient Hamish I. MacLachlan, BSc, MBBS, Jonathan R. Dalzell, MD, MRCP The American Journal of Medicine.

An Unusual Electrocardiogram in a Heart Transplant Recipient Hamish I. MacLachlan, BSc, MBBS, Jonathan R. Dalzell, MD, MRCP The American Journal of Medicine.
Meta-Analysis of Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis  Ashok.

Meta-Analysis of Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis  Ashok.
Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Diabetes: A Meta-Analysis  Stavros Stavrakis, MD  The American Journal.

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Diabetes: A Meta-Analysis  Stavros Stavrakis, MD  The American Journal.
Aortic Dissection and Aortic Aneurysms Associated with Fluoroquinolones: A Systematic Review and Meta-Analysis  Sonal Singh, MD, MPH, Amit Nautiyal, MD 

Aortic Dissection and Aortic Aneurysms Associated with Fluoroquinolones: A Systematic Review and Meta-Analysis  Sonal Singh, MD, MPH, Amit Nautiyal, MD 
The Epidemic of the 20th Century: Coronary Heart Disease

The Epidemic of the 20th Century: Coronary Heart Disease
Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO 

Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO 
Alfred A. Bartolucci, PhD, Michal Tendera, MD, George Howard, DrPH 

Alfred A. Bartolucci, PhD, Michal Tendera, MD, George Howard, DrPH 
Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B

Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B
Ahmed Abuzaid, MD, Carly Fabrizio, DO, Kevin Felpel, MD, Haitham S

Ahmed Abuzaid, MD, Carly Fabrizio, DO, Kevin Felpel, MD, Haitham S
An Unusual Cause of Leg Ulcerations

An Unusual Cause of Leg Ulcerations
Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention  Chirag Bavishi, MD, MPH,

Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention  Chirag Bavishi, MD, MPH,
Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction  Stein Ørn, MD, John G.F. Cleland, MD, Matti.

Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction  Stein Ørn, MD, John G.F. Cleland, MD, Matti.
Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease  Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,

Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease  Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,
Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis  Islam Y. Elgendy,

Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis  Islam Y. Elgendy,
Introduction The American Journal of Medicine

Introduction The American Journal of Medicine
Systematic Review and Meta-analysis of Adverse Events of Low-dose Aspirin and Clopidogrel in Randomized Controlled Trials  Kenneth R. McQuaid, MD, Loren.

Systematic Review and Meta-analysis of Adverse Events of Low-dose Aspirin and Clopidogrel in Randomized Controlled Trials  Kenneth R. McQuaid, MD, Loren.
Wandering Acute Myocardial Infarction

Wandering Acute Myocardial Infarction
Todd A. Lee, PharmD, PhD, Brian Bartle, MPH, Kevin B. Weiss, MD, MPH 

Todd A. Lee, PharmD, PhD, Brian Bartle, MPH, Kevin B. Weiss, MD, MPH 
Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials  Giulia Renda, MD, PhD, Marta.

Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials  Giulia Renda, MD, PhD, Marta.

Similar presentations

Ads by Google